Operation Warp Speed delivers $2bn to scale COVID-19 solutions
Novavax is the principle recipient of the funding, as US government provides capital in return for guaranteed access to doses.
Novavax is the principle recipient of the funding, as US government provides capital in return for guaranteed access to doses.